BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17596857)

  • 1. Comparative skeletal features between Homo floresiensis and patients with primary growth hormone insensitivity (Laron Syndrome).
    Hershkovitz I; Kornreich L; Laron Z
    Am J Phys Anthropol; 2007 Oct; 134(2):198-208. PubMed ID: 17596857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type specimen (LB1) of Homo floresiensis did not have Laron syndrome.
    Falk D; Hildebolt C; Smith K; Jungers W; Larson S; Morwood M; Sutikna T; Jatmiko ; Saptomo EW; Prior F
    Am J Phys Anthropol; 2009 Sep; 140(1):52-63. PubMed ID: 19294744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron syndrome.
    Shevah O; Laron Z
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():489-97. PubMed ID: 17551471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
    Janecka A; Kołodziej-Rzepa M; Biesaga B
    In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homo floresiensis contextualized: a geometric morphometric comparative analysis of fossil and pathological human samples.
    Baab KL; McNulty KP; Harvati K
    PLoS One; 2013; 8(7):e69119. PubMed ID: 23874886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
    Rosenbloom AL
    Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For debate: did the small-bodied hominis from flores (Indonesia) suffer from a molecular defect in the growth hormone receptor gene (Laron syndrome)?
    Laron Z; Kornreich L; Hershkovitz I
    Pediatr Endocrinol Rev; 2006 Jun; 3(4):345-6. PubMed ID: 16816802
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome.
    Al-Ashwal AA; Al-Sagheir A; Ramzan K; Al-Owain M; Allam R; Qari A; Al-Numair NS; Imtiaz F
    Horm Res Paediatr; 2017; 88(2):119-126. PubMed ID: 28743110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
    Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.
    Laron Z; Kauli R; Lapkina L; Werner H
    Mutat Res Rev Mutat Res; 2017; 772():123-133. PubMed ID: 28528685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups.
    Shevah O; Rubinstein M; Laron Z
    Isr Med Assoc J; 2004 Oct; 6(10):630-3. PubMed ID: 15473594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
    Laron Z; Kauli R
    Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).
    Yamamoto H; Kouhara H; Iida K; Chihara K; Kasayama S
    Growth Horm IGF Res; 2008 Apr; 18(2):136-42. PubMed ID: 17728167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homo floresiensis: microcephalic, pygmoid, Australopithecus, or Homo?
    Argue D; Donlon D; Groves C; Wright R
    J Hum Evol; 2006 Oct; 51(4):360-74. PubMed ID: 16919706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
    Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
    J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
    Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
    Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laron syndrome - A historical perspective.
    Laron Z; Werner H
    Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniofacial morphology of Homo floresiensis: description, taxonomic affinities, and evolutionary implication.
    Kaifu Y; Baba H; Sutikna T; Morwood MJ; Kubo D; Saptomo EW; Jatmiko ; Awe RD; Djubiantono T
    J Hum Evol; 2011 Dec; 61(6):644-82. PubMed ID: 22036083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.